ANAVEX LIFE SCIENCES CORP. - 8-K Filing

Anavex Life Sciences submitted a compliance plan to Nasdaq on July 20, 2026, following failure to file its Q1 2026 Form 10-Q.

SEC EDGAR ·

Tickers: $AVXL

Read the full article at SEC EDGAR

More Regulatory news